Provided by Tiger Trade Technology Pte. Ltd.

Zomedica Pharmaceuticals Corp.

0.0973
0.0000
Volume:- -
Turnover:75.35K
Market Cap:95.35M
PE:-1.53
High:0.0973
Open:0.0973
Low:0.0973
Close:0.0973
52wk High:0.1952
52wk Low:0.0920
Shares:979.95M
Float Shares:961.66M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0635
EPS(LYR):-0.0352
ROE:-26.82%
ROA:-9.78%
PB:0.47
PE(LYR):-2.76

Loading ...

Company Profile

Company Name:
Zomedica Pharmaceuticals Corp.
Exchange:
AMEX
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.